Evidera And Symphony Technology Group Announce Appointment Of Simon Kennedy To Senior Leadership Roles

BETHESDA, Md. and PALO ALTO, Calif., Feb. 11, 2014 /PRNewswire/ -- Evidera, a leading provider of evidence-based solutions for the healthcare industry, and Symphony Technology Group (STG) (STG), a strategic private equity firm, today announced that Simon Kennedy has joined Evidera as executive chairman of the board, effective January 1. In this position, he plays a leadership role in defining Evidera's acquisition, new product development and overall growth strategies, working closely with Evidera's management team. Kennedy has also joined STG as healthcare operations partner, and another portfolio company, Symphony Health Solutions, as a member of the board of directors.

(Logo: http://photos.prnewswire.com/prnh/20140211/NE62531LOGO)

STG, founded in 2002, has raised $2 billion in equity capital and has a demonstrated track record of leveraging its operational expertise and commitment to innovation to transform midsize enterprise technology and services companies. Across all three roles, Kennedy's focus will be on finding innovative ways to leverage information and analytics to deliver real, measurable value to healthcare companies. He will build on both the powerful combination of assets and capabilities Evidera and SHS already possess and leverage STG as a rich investment platform for creating new capabilities, both through organic investment and acquisition.

"I'm tremendously excited about the potential for STG and our portfolio of companies to play a significant role in the transformation of the global healthcare system," said Kennedy. "We believe we have the opportunity to help create a system that is more efficient, effective and equitable as the result of applying complex analytics to new and emerging sources of data."

Kennedy was most recently a senior partner and managing director at the Boston Consulting Group (www.BCG.com) where he was the founder and global leader of the firm's health care information technology (HCIT) practice, a member of the committee responsible for BCG's Value Based Healthcare investments and research and responsible for leading projects across the entire healthcare value chain. Prior to BCG, Kennedy was a principal at Booz, Allen & Hamilton, a lecturer at the University of Cape Town, in South Africa, co-founder of boutique strategy consulting firm Strategy*Partners and a senior consultant in the Software Engineering Support Group at Price Waterhouse.

For more information, visit www.evidera.com and www.symphonytg.com.

About Evidera
Evidera, a wholly owned subsidiary of Symphony Technology Group, provides health economics, outcomes research, market access, data analytics and epidemiology services. We partner with life sciences organizations worldwide to optimize the market access and commercial success of their products by leveraging our unparalleled knowledge of the global payer and regulator landscape and by developing, capturing and communicating the clinical and economic evidence that our clients require to successfully market their products. Our research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities.

About Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great technology and services companies. In addition to capital, STG provides transformation expertise to enable its companies to deliver maximum value to their clients, to drive growth through innovation, to retain and attract the best talent and to achieve best in class business performance. STG's current portfolio consists of 14 global companies. For more information, please visit www.symphonytg.com.

About Symphony Health Solutions
Symphony Health Solutions helps clients grow and enables a transformation of the healthcare ecosystem by providing best-in-class information, analytics and technology solutions with actionable insights. The company connects and integrates a broad set of primary and secondary health research, analytics and consulting, leveraging this rich data to deliver a comprehensive perspective on the real dynamics that drive business in the life sciences market. For more information, visit www.symphonyhealth.com.

Media Contacts:
Susan Potter Couch, Director Marketing and Communications
[email protected]
301-664-7286

Laura Maas, InkHouse
(On behalf of Symphony Technology Group)
[email protected]
781-966-4124

SOURCE Evidera